Endiatx's Journey: From Idea to Revolutionary MedTech with Torrey Smith and Chris Green
In this episode of the Med Tech Startup Podcast, we dive deep into the journey of Endiatx, a groundbreaking medical device startup focused on developing swallowable robotic pills for diagnostics and treatment. Co-founder and CEO Torrey Smith and Chief Business Officer Chris Green share their personal and professional backgrounds, detailing the evolution of Endiatx from a mere idea sketched in notebooks to a company with a vision to transform endoscopy and diagnostics. Despite facing challenges such as skepticism, technical hurdles, and funding obstacles, Endiatx's commitment to their dream has begun to pay off with successful demonstrations, strategic partnerships, and substantial funding rounds. From Burning Man to MedTech Malta and beyond, their story encourages aspiring entrepreneurs to pursue their audacious goals, emphasizing the importance of team building, perseverance, and swinging for the fences.
00:00 The Journey from Solo Sketching to Team Triumph
01:02 Diving into the MedTech Startup Podcast
01:59 The Significance of MedTech Malta for Endiatx
03:50 Facing Challenges and Embracing Failures on Stage
08:43 The Founders' Personal Journeys and the American Dream
12:58 The Vision and Mission of Endiatx
22:46 The Power of Entrepreneurship and Team Building
33:41 The Intense Passion Driving Endiatx
35:42 Navigating the Complexities of Fundraising in Silicon Valley
36:27 The Highs and Lows of MedTech Malta: A Fundraising Adventure
39:07 From Burning Man to Silicon Valley: The Unconventional Journey of Endiatx
43:40 The Evolution of a Startup: Learning, Growing, and Embracing Change
44:45 Memorable Moments and the Power of the First Check
59:01 The Future of Fundraising and the Vision for Endiatx
01:03:07 A Call to Action for Aspiring Entrepreneurs
01:08:17 Wrapping Up: The Endiatx Story and Its Impact
Informations
- Émission
- FréquenceChaque semaine
- Publiée18 mars 2024 à 19:00 UTC
- Durée1 h 9 min
- Saison1
- Épisode18
- ClassificationTous publics